FDA warning letter
Issue date
10 Feb 2020
Issuing office
Division of Pharmaceutical Quality Operations I
Posted date
3 Mar 2020
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Products & Services
Drugs
Acino Pharma
Manufacturer
Audited
Audit report available
Warning letter
Headquarters
SwitzerlandSites
EstoniaSwitzerland
Germany